Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.

Author: EnkeBeate, GallHenning, GhofraniHossein A, GrimmingerFriedrich, KreckelAndre, KrickStefanie, OlschewskiHorst, ReichenbergerFrank, RubinLewis J, SchermulyRalph Theo, SeegerWerner, VoswinckelRobert

Paper Details 
Original Abstract of the Article :
BACKGROUND: Inhaled treprostinil was recently developed for the treatment of pulmonary arterial hypertension (PAH). We investigated the safety and acute haemodynamic effects of the combination oral sildenafil and inhaled treprostinil in an open label study in patients with precapillary pulmonary hyp...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.pupt.2008.07.003

データ提供:米国国立医学図書館(NLM)

Unlocking the Potential of Combined Therapies for Pulmonary Hypertension

Pulmonary hypertension (PH), a condition characterized by high blood pressure in the arteries of the lungs, poses a significant challenge in the realm of cardiovascular medicine. This research investigates the potential benefits of combining two existing therapies, inhaled treprostinil and oral sildenafil, for the treatment of PH. The study employed an open label design, evaluating the safety and acute haemodynamic effects of this combination therapy in patients with precapillary PH.

A Synergistic Approach to Reducing Pulmonary Pressure

The study found that the combination of sildenafil and inhaled treprostinil was well tolerated and led to additive pulmonary-selective vasodilation, resulting in a significant reduction in pulmonary vascular resistance and mean pulmonary arterial pressure. The authors concluded that this synergistic effect could hold promise for both short-term and long-term management of PH patients, including those with pulmonary arterial hypertension (PAH) and non-operable chronic thromboembolic pulmonary hypertension (CTEPH). Notably, these positive effects were observed across different patient subgroups.

Harnessing the Power of Combination Therapies

This research presents a compelling case for exploring combination therapies as a potential breakthrough in PH treatment. It suggests that combining different medications with complementary mechanisms of action might offer a more effective approach to managing this challenging condition. Further research is needed to understand the long-term benefits and potential side effects of this combination therapy.

Dr.Camel's Conclusion

Imagine PH as a sandstorm raging through the lungs, making it difficult to breathe. This study explores the concept of using a combination of medications like sildenafil and inhaled treprostinil to create a “sandstorm shield,” effectively reducing pressure and improving lung function. The findings suggest that this synergistic approach could be a valuable tool in combating the challenges of PH, much like a desert nomad strategically using different resources to navigate a harsh environment.

Date :
  1. Date Completed 2009-02-19
  2. Date Revised 2022-03-21
Further Info :

Pubmed ID

18657627

DOI: Digital Object Identifier

10.1016/j.pupt.2008.07.003

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.